New York,  NY 
United States

Pfizer Oncology is committed to advancing medicines wherever we believe we can make a difference for people living with cancer. We have an industry-leading portfolio of 24 approved cancer medicines & biosimilars across 30+ indications—and are focused on delivering breakthroughs in breast and genitourinary cancer, hematology and precision medicine.